Taysha Gene Therapies, Inc. SEC filings TSHA

Taysha Gene Therapies, Inc. has 401 filings in SEC EDGAR's recent list, going back to May 4, 2020. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Taysha Gene Therapies, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
4 Insider transaction Jul 10, 2026 Jul 10, 2026
144 Notice of proposed sale Jul 10, 2026 —
8-K Current report
Material agreement, Other events
Jun 25, 2026 Jun 24, 2026
424B5 Prospectus supplement Jun 25, 2026 —
424B5 Prospectus supplement Jun 24, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 22, 2026 Jun 22, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
8-K Current report
Shareholder vote results
Jun 2, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 1, 2026
4 Insider transaction Apr 13, 2026 Apr 10, 2026
144 Notice of proposed sale Apr 10, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
144 Notice of proposed sale Feb 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 6, 2026 Feb 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 12, 2026 —
S-8 Employee stock plan registration Jan 6, 2026 —
4 Insider transaction Dec 1, 2025 Nov 28, 2025
144 Notice of proposed sale Nov 28, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3ASR Automatic shelf registration Nov 4, 2025 —
8-K Current report
Material agreement, Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 16, 2025 Oct 16, 2025
8-K Current report
Other events
Oct 9, 2025 Oct 9, 2025
8-K Current report
Other events
Oct 2, 2025 Oct 2, 2025
144 Notice of proposed sale Sep 22, 2025 —
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
4 Insider transaction Aug 22, 2025 Aug 21, 2025
4 Insider transaction Aug 22, 2025 Aug 21, 2025
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 21, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 3, 2025 —
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 3, 2025 —
4 Insider transaction Jun 3, 2025 May 30, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 3, 2025 Jun 2, 2025
8-K Current report
Material agreement, Other events
May 29, 2025 May 28, 2025
424B5 Prospectus supplement May 29, 2025 —
8-K/A Amended current report
Regulation FD disclosure, Other events
May 29, 2025 May 28, 2025
424B5 Prospectus supplement May 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
May 28, 2025 May 28, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
DEFR14A Filing May 9, 2025 —
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 21, 2025 —
DEF 14A Proxy statement Apr 21, 2025 Jun 2, 2025
4/A Filing Apr 10, 2025 May 31, 2023
PRE 14A Preliminary proxy statement Apr 10, 2025 Jun 2, 2025
4 Insider transaction Mar 13, 2025 Mar 11, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
S-8 Employee stock plan registration Jan 7, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
EFFECT Filing Dec 20, 2024 —
CORRESP Letter to the SEC Dec 20, 2024 —
CORRESP Letter to the SEC Dec 19, 2024 —
UPLOAD Letter from the SEC Dec 18, 2024 —
S-3 Shelf registration Dec 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
144 Notice of proposed sale Jul 5, 2024 —
144 Notice of proposed sale Jul 5, 2024 —
144 Notice of proposed sale Jul 5, 2024 —
4 Insider transaction Jul 1, 2024 Jun 27, 2024
8-K Current report
Material agreement, Other events
Jun 26, 2024 Jun 26, 2024
424B5 Prospectus supplement Jun 26, 2024 —
8-K Current report
Results of operations, Other events
Jun 26, 2024 Jun 25, 2024
424B5 Prospectus supplement Jun 26, 2024 —
8-K Current report
Regulation FD disclosure
Jun 18, 2024 Jun 18, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
8-K Current report
Shareholder vote results
May 30, 2024 May 29, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
DEFA14A Additional proxy material Apr 18, 2024 —
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 18, 2024 May 29, 2024
S-8 Employee stock plan registration Mar 19, 2024 —
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Feb 6, 2024 Feb 2, 2024
8-K Current report
Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
8-K Current report
Officer or director change
Dec 20, 2023 Dec 14, 2023
S-8 Employee stock plan registration Dec 20, 2023 —
4 Insider transaction Dec 18, 2023 Dec 14, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
4 Insider transaction Nov 20, 2023 Nov 17, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Nov 15, 2023 Nov 15, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
3 Initial insider ownership Nov 3, 2023 Nov 1, 2023
8-K Current report
Officer or director change
Nov 1, 2023 Oct 30, 2023
DEF 14A Proxy statement Oct 5, 2023 Nov 15, 2023
8-K Current report
Regulation FD disclosure
Sep 26, 2023 Sep 26, 2023
PRE 14A Preliminary proxy statement Sep 21, 2023 Nov 15, 2023
8-K Current report
Other events
Sep 19, 2023 Sep 19, 2023
424B3 Prospectus Sep 11, 2023 —
SC 13G/A Amended ownership over 5% (passive) Sep 11, 2023 —
EFFECT Filing Sep 8, 2023 —
CORRESP Letter to the SEC Sep 7, 2023 —
UPLOAD Letter from the SEC Sep 6, 2023 —
S-3 Shelf registration Aug 30, 2023 —
8-K Current report
Other events
Aug 29, 2023 Aug 28, 2023
SC 13G Ownership over 5% (passive) Aug 28, 2023 —
SC 13G Ownership over 5% (passive) Aug 25, 2023 —
4 Insider transaction Aug 25, 2023 Aug 24, 2023
D Filing Aug 25, 2023 —
SC 13G Ownership over 5% (passive) Aug 25, 2023 —
144 Notice of proposed sale Aug 24, 2023 —
8-K Current report
Other events
Aug 24, 2023 Aug 24, 2023
SC 13D/A Amended ownership over 5% (active) Aug 21, 2023 —
SC 13D/A Amended ownership over 5% (active) Aug 18, 2023 —
4 Insider transaction Aug 16, 2023 Aug 16, 2023
4 Insider transaction Aug 16, 2023 Aug 16, 2023
4 Insider transaction Aug 16, 2023 Aug 16, 2023
4 Insider transaction Aug 16, 2023 Aug 16, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Aug 14, 2023 Aug 14, 2023
8-K Current report
Listing notice
Aug 4, 2023 Aug 3, 2023
8-K Current report
Regulation FD disclosure
Jul 31, 2023 Jul 31, 2023
4 Insider transaction Jul 14, 2023 Jul 12, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TSHA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Dallas, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1806310

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.